Global Organ Transplant Immunosuppressant Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Organ Transplant Immunosuppressant Market
Immunosuppressants are a class of drugs that suppress the immune response through various mechanisms. In organ transplantation, immunosuppressants are used to prevent the body from either recognition or attacking the foreign organ via various immune responses. They should only be used under the supervision of appropriately trained and experienced staff.

Due to the COVID-19 pandemic, the global Organ Transplant Immunosuppressant market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Tacrolimus accounting for % of the Organ Transplant Immunosuppressant global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Liver Transplant segment is altered to an % CAGR throughout this forecast period.

In China, Organ Transplant Immunosuppressant key players include Roche, Astellas Pharma Inc., Huadong Pharmaceutical, Novartis, etc.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Tacrolimus

Mycophenolate Mofetil

Cyclosporin

Others

Segment by Application

Liver Transplant

Kidney Transplant

Heart Transplant

Other Organ Transplant

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Organ Transplant Immunosuppressant market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Roche

Astellas Pharma Inc.

Huadong Pharmaceutical

Novartis

Catalent Pharma

Cinkate Corporation

Cilag

Genzyme

Changzhou Pharm

North China Pharmaceutical Group Corporation

SL PHARM

Livzon Pharmaceutical Group Inc.,

TABLE OF CONTENT

1 Study Coverage
1.1 Organ Transplant Immunosuppressant Product Introduction

1.2 Market by Type

1.2.1 Global Organ Transplant Immunosuppressant Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Tacrolimus

1.2.3 Mycophenolate Mofetil

1.2.4 Cyclosporin

1.2.5 Others

1.3 Market by Application

1.3.1 Global Organ Transplant Immunosuppressant Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Liver Transplant

1.3.3 Kidney Transplant

1.3.4 Heart Transplant

1.3.5 Other Organ Transplant

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Organ Transplant Immunosuppressant Sales Estimates and Forecasts 2017-2028

2.2 Global Organ Transplant Immunosuppressant Revenue Estimates and Forecasts 2017-2028

2.3 Global Organ Transplant Immunosuppressant Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Organ Transplant Immunosuppressant Sales by Region

2.4.1 Global Organ Transplant Immunosuppressant Sales by Region (2017-2022)

2.4.2 Global Sales Organ Transplant Immunosuppressant by Region (2023-2028)

2.5 Global Organ Transplant Immunosuppressant Revenue by Region

2.5.1 Global Organ Transplant Immunosuppressant Revenue by Region (2017-2022)

2.5.2 Global Organ Transplant Immunosuppressant Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Organ Transplant Immunosuppressant Sales by Manufacturers

3.1.1 Global Top Organ Transplant Immunosuppressant Manufacturers by Sales (2017-2022)

3.1.2 Global Organ Transplant Immunosuppressant Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Organ Transplant Immunosuppressant in 2021

3.2 Global Organ Transplant Immunosuppressant Revenue by Manufacturers

3.2.1 Global Organ Transplant Immunosuppressant Revenue by Manufacturers (2017-2022)

3.2.2 Global Organ Transplant Immunosuppressant Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Organ Transplant Immunosuppressant Revenue in 2021

3.3 Global Organ Transplant Immunosuppressant Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Organ Transplant Immunosuppressant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Organ Transplant Immunosuppressant Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Organ Transplant Immunosuppressant Sales by Type

4.1.1 Global Organ Transplant Immunosuppressant Historical Sales by Type (2017-2022)

4.1.2 Global Organ Transplant Immunosuppressant Forecasted Sales by Type (2023-2028)

4.1.3 Global Organ Transplant Immunosuppressant Sales Market Share by Type (2017-2028)

4.2 Global Organ Transplant Immunosuppressant Revenue by Type

4.2.1 Global Organ Transplant Immunosuppressant Historical Revenue by Type (2017-2022)

4.2.2 Global Organ Transplant Immunosuppressant Forecasted Revenue by Type (2023-2028)

4.2.3 Global Organ Transplant Immunosuppressant Revenue Market Share by Type (2017-2028)

4.3 Global Organ Transplant Immunosuppressant Price by Type

4.3.1 Global Organ Transplant Immunosuppressant Price by Type (2017-2022)

4.3.2 Global Organ Transplant Immunosuppressant Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Organ Transplant Immunosuppressant Sales by Application

5.1.1 Global Organ Transplant Immunosuppressant Historical Sales by Application (2017-2022)

5.1.2 Global Organ Transplant Immunosuppressant Forecasted Sales by Application (2023-2028)

5.1.3 Global Organ Transplant Immunosuppressant Sales Market Share by Application (2017-2028)

5.2 Global Organ Transplant Immunosuppressant Revenue by Application

5.2.1 Global Organ Transplant Immunosuppressant Historical Revenue by Application (2017-2022)

5.2.2 Global Organ Transplant Immunosuppressant Forecasted Revenue by Application (2023-2028)

5.2.3 Global Organ Transplant Immunosuppressant Revenue Market Share by Application (2017-2028)

5.3 Global Organ Transplant Immunosuppressant Price by Application

5.3.1 Global Organ Transplant Immunosuppressant Price by Application (2017-2022)

5.3.2 Global Organ Transplant Immunosuppressant Price Forecast by Application (2023-2028)

6 North America

6.1 North America Organ Transplant Immunosuppressant Market Size by Type

6.1.1 North America Organ Transplant Immunosuppressant Sales by Type (2017-2028)

6.1.2 North America Organ Transplant Immunosuppressant Revenue by Type (2017-2028)

6.2 North America Organ Transplant Immunosuppressant Market Size by Application

6.2.1 North America Organ Transplant Immunosuppressant Sales by Application (2017-2028)

6.2.2 North America Organ Transplant Immunosuppressant Revenue by Application (2017-2028)

6.3 North America Organ Transplant Immunosuppressant Market Size by Country

6.3.1 North America Organ Transplant Immunosuppressant Sales by Country (2017-2028)

6.3.2 North America Organ Transplant Immunosuppressant Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Organ Transplant Immunosuppressant Market Size by Type

7.1.1 Europe Organ Transplant Immunosuppressant Sales by Type (2017-2028)

7.1.2 Europe Organ Transplant Immunosuppressant Revenue by Type (2017-2028)

7.2 Europe Organ Transplant Immunosuppressant Market Size by Application

7.2.1 Europe Organ Transplant Immunosuppressant Sales by Application (2017-2028)

7.2.2 Europe Organ Transplant Immunosuppressant Revenue by Application (2017-2028)

7.3 Europe Organ Transplant Immunosuppressant Market Size by Country

7.3.1 Europe Organ Transplant Immunosuppressant Sales by Country (2017-2028)

7.3.2 Europe Organ Transplant Immunosuppressant Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Organ Transplant Immunosuppressant Market Size by Type

8.1.1 Asia Pacific Organ Transplant Immunosuppressant Sales by Type (2017-2028)

8.1.2 Asia Pacific Organ Transplant Immunosuppressant Revenue by Type (2017-2028)

8.2 Asia Pacific Organ Transplant Immunosuppressant Market Size by Application

8.2.1 Asia Pacific Organ Transplant Immunosuppressant Sales by Application (2017-2028)

8.2.2 Asia Pacific Organ Transplant Immunosuppressant Revenue by Application (2017-2028)

8.3 Asia Pacific Organ Transplant Immunosuppressant Market Size by Region

8.3.1 Asia Pacific Organ Transplant Immunosuppressant Sales by Region (2017-2028)

8.3.2 Asia Pacific Organ Transplant Immunosuppressant Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Organ Transplant Immunosuppressant Market Size by Type

9.1.1 Latin America Organ Transplant Immunosuppressant Sales by Type (2017-2028)

9.1.2 Latin America Organ Transplant Immunosuppressant Revenue by Type (2017-2028)

9.2 Latin America Organ Transplant Immunosuppressant Market Size by Application

9.2.1 Latin America Organ Transplant Immunosuppressant Sales by Application (2017-2028)

9.2.2 Latin America Organ Transplant Immunosuppressant Revenue by Application (2017-2028)

9.3 Latin America Organ Transplant Immunosuppressant Market Size by Country

9.3.1 Latin America Organ Transplant Immunosuppressant Sales by Country (2017-2028)

9.3.2 Latin America Organ Transplant Immunosuppressant Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Organ Transplant Immunosuppressant Market Size by Type

10.1.1 Middle East and Africa Organ Transplant Immunosuppressant Sales by Type (2017-2028)

10.1.2 Middle East and Africa Organ Transplant Immunosuppressant Revenue by Type (2017-2028)

10.2 Middle East and Africa Organ Transplant Immunosuppressant Market Size by Application

10.2.1 Middle East and Africa Organ Transplant Immunosuppressant Sales by Application (2017-2028)

10.2.2 Middle East and Africa Organ Transplant Immunosuppressant Revenue by Application (2017-2028)

10.3 Middle East and Africa Organ Transplant Immunosuppressant Market Size by Country

10.3.1 Middle East and Africa Organ Transplant Immunosuppressant Sales by Country (2017-2028)

10.3.2 Middle East and Africa Organ Transplant Immunosuppressant Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Roche

11.1.1 Roche Corporation Information

11.1.2 Roche Overview

11.1.3 Roche Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Roche Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Roche Recent Developments

11.2 Astellas Pharma Inc.

11.2.1 Astellas Pharma Inc. Corporation Information

11.2.2 Astellas Pharma Inc. Overview

11.2.3 Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Astellas Pharma Inc. Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Astellas Pharma Inc. Recent Developments

11.3 Huadong Pharmaceutical

11.3.1 Huadong Pharmaceutical Corporation Information

11.3.2 Huadong Pharmaceutical Overview

11.3.3 Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Huadong Pharmaceutical Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Huadong Pharmaceutical Recent Developments

11.4 Novartis

11.4.1 Novartis Corporation Information

11.4.2 Novartis Overview

11.4.3 Novartis Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Novartis Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Novartis Recent Developments

11.5 Catalent Pharma

11.5.1 Catalent Pharma Corporation Information

11.5.2 Catalent Pharma Overview

11.5.3 Catalent Pharma Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Catalent Pharma Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Catalent Pharma Recent Developments

11.6 Cinkate Corporation

11.6.1 Cinkate Corporation Corporation Information

11.6.2 Cinkate Corporation Overview

11.6.3 Cinkate Corporation Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Cinkate Corporation Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Cinkate Corporation Recent Developments

11.7 Cilag

11.7.1 Cilag Corporation Information

11.7.2 Cilag Overview

11.7.3 Cilag Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Cilag Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Cilag Recent Developments

11.8 Genzyme

11.8.1 Genzyme Corporation Information

11.8.2 Genzyme Overview

11.8.3 Genzyme Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Genzyme Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Genzyme Recent Developments

11.9 Changzhou Pharm

11.9.1 Changzhou Pharm Corporation Information

11.9.2 Changzhou Pharm Overview

11.9.3 Changzhou Pharm Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Changzhou Pharm Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Changzhou Pharm Recent Developments

11.10 North China Pharmaceutical Group Corporation

11.10.1 North China Pharmaceutical Group Corporation Corporation Information

11.10.2 North China Pharmaceutical Group Corporation Overview

11.10.3 North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 North China Pharmaceutical Group Corporation Recent Developments

11.11 SL PHARM

11.11.1 SL PHARM Corporation Information

11.11.2 SL PHARM Overview

11.11.3 SL PHARM Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)

11.11.4 SL PHARM Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 SL PHARM Recent Developments

11.12 Livzon Pharmaceutical Group Inc.,

11.12.1 Livzon Pharmaceutical Group Inc., Corporation Information

11.12.2 Livzon Pharmaceutical Group Inc., Overview

11.12.3 Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales, Price, Revenue and Gross Margin (2017-2022)

11.12.4 Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Livzon Pharmaceutical Group Inc., Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Organ Transplant Immunosuppressant Industry Chain Analysis

12.2 Organ Transplant Immunosuppressant Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Organ Transplant Immunosuppressant Production Mode & Process

12.4 Organ Transplant Immunosuppressant Sales and Marketing

12.4.1 Organ Transplant Immunosuppressant Sales Channels

12.4.2 Organ Transplant Immunosuppressant Distributors

12.5 Organ Transplant Immunosuppressant Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Organ Transplant Immunosuppressant Industry Trends

13.2 Organ Transplant Immunosuppressant Market Drivers

13.3 Organ Transplant Immunosuppressant Market Challenges

13.4 Organ Transplant Immunosuppressant Market Restraints

14 Key Findings in The Global Organ Transplant Immunosuppressant Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample